GlassScriptPhysician profile
Aseem Malhotra
NPI 1942654041
$56,069.62
in general payments reported to CMS, 2019-2025
22 companies · $16K in 2025
The $16K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $685 · 2021: $35K · 2022: $986 · 2023: $169 · 2024: $2,850 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $2,301 · Honoraria: $2,040 · Travel and Lodging: $99.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,958.00 |
| Food and Beverage | $2,300.97 |
| Honoraria | $2,040.00 |
| Travel and Lodging | $99.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $35,017.19 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $12,762.34 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Ferring Pharmaceuticals INC. | $3,131.01 | 2025 | Adstiladrin |
| Urogen Pharma, INC. | $2,309.24 | 2024 | |
| Intuitive Surgical, INC. | $736.76 | 2022 | |
| Medtronic USA, INC. | $518.03 | 2019 | |
| Calyxo, INC. | $341.69 | 2024-2025 | Cvac Aspiration System |
| Teleflex LLC | $230.39 | 2022-2023 | Urolift |
| Sun Pharmaceutical Industries INC. | $190.12 | 2023-2024 | |
| Bioprotect Medical, INC. | $135.68 | 2024 | Bioprotect Balloon Implant System |
| Dendreon Pharmaceuticals LLC | $130.73 | 2025 | Provenge |
| Merck Sharp & Dohme LLC | $106.30 | 2024 | Lynparza |
| Neotract INC. | $90.92 | 2019 | |
| Baxter Healthcare | $75.87 | 2019 | |
| Tempus Ai, INC | $73.09 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $43.28 | 2025 | |
| Olympus America INC. | $42.37 | 2023 | Itind System |
| Abbvie INC. | $33.16 | 2025 | |
| Janssen Biotech, INC. | $29.90 | 2025 | Erleada |
| Photocure INC | $29.36 | 2022 | |
| Abbott Laboratories | $24.52 | 2025 | Amplatzer Amulet |
| Accord Healthcare, INC. | $17.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aseem Malhotra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.